not tagged
eli lilly
['mantle,(-dismantle)', 'lymphoma', 'lymsm', 'valent ,(-prevalent)', 'loxo', 'valent ,(-prevalent),(-equivalent),(-bivalent)']
learn about patient-reported outcomes among patients w/ #mantlecelllymphoma receiving a highly selective, non-covalent (reversible) btk inhibitor after prior covalent btk inhibitor (cbtki) treatment. #lymsm #eha2023 poster presentation: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK